Molecular biology of mineralocorticoid metabolism

Annual Review of Nutrition

Volumn 16, Issue , 1996, Pages 443-470

  Fardella, Carlos E ^a   Miller, Walter L ^b  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

aldosterone; hypertension; salt; steroids

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; 3(OR 17)BETA HYDROXYSTEROID DEHYDROGENASE; CORTISONE; GLUCOCORTICOID RECEPTOR; HYDROCORTISONE; MINERALOCORTICOID; MINERALOCORTICOID RECEPTOR; STEROID 11BETA MONOOXYGENASE; STEROID 17ALPHA MONOOXYGENASE; STEROID 21 MONOOXYGENASE;

CONGENITAL ADRENAL HYPERPLASIA; CORTICOSTEROID METABOLISM; ENZYME DEFICIENCY; ESSENTIAL HYPERTENSION; HEREDITARY HYPERTENSION; HUMAN; NONHUMAN; PRIORITY JOURNAL; RECEPTOR AFFINITY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SALT LOSING NEPHRITIS; STEROID 21 MONOOXYGENASE DEFICIENCY; TRANSGENIC MOUSE;

EID: 0029799269     PISSN: 01999885     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.nu.16.070196.002303     Document Type: Review

References (130)

1. Agarwal AK, Rogerson FM, Mune T, White PC. 1995. Gene structure and chromosomal localization of the human HSD11K gene encoding the kidney (type 2) isozyme of 11β-hydroxysteroid dehydrogenase. Genomics 29:195-99
2. Agarwal AK, Tusie-Luna M, Monder C, White PC. 1990. Expression of 11β-hydroxysteroid dehydrogenase using recombinant vaccinia virus. Mol. Endocrinol. 4:1827-32
3. Albiston AL, Obeyesekere VR, Smith RE, Krozowski ZS. 1994. Cloning and tissue distribution of the human 11β-hydroxysteroid dehydrogenase type II enzyme. Mol. Cell. Endocrinol. 105: R11-17
4. Alnemri ES, Maksymowych AB, Robertson NM, Litwach G. 1991. Overexpression and characterization of the human mineralocorticoid receptor. J. Biol. Chem. 266:18072-81
5. Arriza JL, Weinberger C, Cerelli G, Glaser TM, Handelin BL, et al. 1987. Cloning of human mineralocorticoid receptor DNA: structural and functional kinship with the glucocorticoid receptor. Science 237:268-75
6. Baxter JD, Perloff D, Hsueh W, Biglieri EG. 1995. The endocrinology of hypertension. In Endocrinology and Metabolism, ed. P Felig, JD Baxter, LA Frohman, pp. 749-853. New York: McGraw-Hill. 3rd ed.
7. Beato M. 1989. Gene regulation by steroid hormones. Cell 56:335-44
8. Bérubé D, Luu-The V, Lachance Y, Gagne R, Labrie F. 1989. Assignment of the human 3β-hydroxysteroid dehydrogenase gene (HSDB3) to the p13 band of chromosome 1. Cytogenet. Cell. Genet. 52:199-200
9. Binart N, Lombes M, Rafestin-Oblin M-E, Baulieu E-E. 1991. Characterization of human mineralocorticoid receptor expressed in the baculovirus system. Proc. Natl. Acad. Sci. USA 88: 10681-85
10. +-dependent isoform. Endocrinology 132:2614-21
11. Cara JF, Moshang T Jr, Bongiovanni AM, Marx BS. 1985. Elevated 17-hydroxy-progesterone and testosterone in a newborn with 3β-hydroxysteroid dehydrogenase deficiency. N. Engl. J. Med. 313:618-21
12. Carroll J, Komanicky P, Melby JC. 1981. The relationship between plasma 18 - hydroxy - 11 - deoxycorticosterone levels and production of hypertension in the rat. J. Steroid Biochem. 14:989-95
13. Carson-Jurica MA, Schrader WT, O'Malley BW. 1990. Steroid receptor family: structure and functions. Endocrin. Rev. 11:201-20
14. Casey ML, Guerami A, Milewich L, Gomer-Sanchez CE, MacDonald PC. 1985. Origin of urinary non-conjugated 19-nor-deoxycorticosterone and metabolism of infused radio-labeled 19-nordeoxycorticosterone in men and women. J. Clin. Invest. 75:1335-38
15. Casey ML, MacDonald PC. 1982. Extra-adrenal formation of a mineralocorticoid: deoxycorticosterone and deoxycorticosterone sulfate biosynthesis and metabolism. Endocrin. Rev. 3:396-403
16. Chang YT, Kappy MS, Iwamoto K, Wang X, Pang S. 1993. Mutations in the type II 3β-hydroxysteroid dehydrogenase gene in a patient with classic salt-wasting 3β-HSD deficiency congenital adrenal hyperplasia. Pediatr. Res. 34:698-700
17. Chang YT, Zhang L, Alkaddour HS, Mason JI, Lin K, et al. 1995. Absence of molecular defect in the type II 3β-hydroxysteroid dehydrogenase (3β-HSD) gene in premature pubarche children and hirsute female patients with moderately decreased adrenal 3β-HSD activity. Pediatr. Res. 37:820-24
18. Chung B, Picado-Leonard J, Haniu M, Bienkowski M, Hall PF, et al. 1987. Cytochrome P450c17 (steroid 17α-hydroxylase/17,20 lyase): cloning of human adrenal and testis cDNAs indicates the same gene is expressed in both tissues. Proc. Natl. Acad. Sci. USA 84: 407-11
19. Cicila GT, Rapp JP, Wang J-M, St Lezin E, Ng SC, Kurtz TW. 1993. Linkage of 11β-hydroxylase mutations with altered steroid biosynthesis blood pressure in the Dahl rat. Nature Genet. 3:346-53
20. Clark BJ, Wells J, King SR, Stocco DM. 1994. The purification, cloning and expression of a novel luteinizing hormone-induced mitochondrial protein in MA-10 cells mouse Leydig tumor cells. Characterization of the steroidogenic acute regulatory protein (StAR). J. Biol. Chem. 269:28314-22
21. Cover CM, Wang JM, St Letzin E, Kurtz TW, Mellon SH. 1995. Molecular variants in the P450c11AS gene as determinants of aldosterone synthase activity in the Dahl rat model of hypertension. J. Biol. Chem. 270:16555-60
22. Curnow KM, Tusie-Luna M, Pascoe L, Natarajan R, Gu J, et al. 1991. The product of the CYP11B2 gene is required for aldosterone biosynthesis in the human adrenal cortex. Mol. Endocrinol. 5:1513-22
23. D'Armiento M, Reda G, Kater C, Shackleton CHL, Biglieri EG. 1983. 17α-Hydroxylase deficiency: mineralocorticoid hormone profiles in an affected family. J. Clin. Endocrinol. Metab. 56: 697-701
24. Dale SL, Holbrook MM, Melby JC. 1985. 19-Nor-deoxycorticosteorne in rats bred for susceptibility and resistance to the hypertensive effects of salt. Endocrinology 117:2424-27
25. Deschepper CF, Mellon SH, Cumin F, Baxter JD, Ganong WF. 1986. Analysis by immunocytochemistry and in situ hybridization of renin and its mRNA in kidney testis, adrenal and pituitary of the rat. Proc. Natl. Acad. Sci. USA 83: 7552-56
26. Edwards CR, Stewart PM, Burt D, Brett L, McIntyre MA, et al. 1988. Localisation of 11β-hydroxysteroid dehydrogenase-tissue specific protector of the mineralocorticoid receptor. Lancet 2: 986-89
27. Eisen LP, Harmon JM. 1986. Activation of the rat kidney mineralocorticoid receptor. Endocrinology 119:1419-26
28. Epstein LF, Orme-Johnson NR. 1991. Regulation of steroid hormone biosynthesis. Identification of precursors of a phosphoprotein targeted to the mitochondrion in stimulated rat adrenal cortex cells. J. Biol. Chem. 266:19739-45
29. Evans RM. 1988. The steroid and thyroid hormone receptor superfamily. Science 240:889-95
30. Fardella CE, Hum DW, Homoki J, Miller WL. 1994. Point mutation Arg 440 to His in cytochrome P450c17 causes severe 17α-hydroxylase deficiency. J. Clin. Endocrinol. Metab. 79: 160-64
31. Fardella CE, Hum DW, Rodriguez H, Zhang G, Barry F, et al. 1996. Gene conversion in the CYP11B2 gene encoding aldosterone synthase (P450c11AS) is associated with, but does not cause, the syndrome of corticosterone methyl oxidase II deficiency. J. Clin. Endocrinol. Metab. 81:321-26
32. Fardella CE, Rodriguez H, Hum DW, Mellon SH, Miller WL. 1995. Artificial mutations in P450c11AS (aldosterone synthase) can increase enzymatic activity: a model for low-renin hypertension? J. Clin. Endocrinol. Metab. 80:1040-43
33. 489 in human cytochrome P450c17 causes severe 17α-hydroxylase deficiency. J. Clin. Endocrinol. Metab. 77: 489-93
34. Ferguson JJ. 1963. Protein synthesis and adrenocorticotropin responsiveness. J. Biol. Chem. 238:2754-59
35. Ferrari P, Bianchi G. 1995. Lessons from experimental genetic hypertension. In Hypertension: Pathophysiology, Diagnosis and Management, ed. JH Laragh, BM Brenner, pp. 1261-79. New York: Raven. 2nd ed.
36. Funder JW. 1994. Corticosteroid receptors and the central nervous system. J. Steroid Biochem. Mol. Biol. 49:381-84
37. Funder JW, Mercer J, Ingram B, Feldman D, Wynne K, Adam WR. 1978. 19-Nor-deoxycorticosterone (19-nor-DOC): mineralocorticoid receptor affinity higher than aldosterone, electrolyte activity lower. Endocrinology 103: 1514-17
38. Funder JW, Pearce PT, Smith R, Smith I. 1988. Mineralocorticoid action: Target tissue specificity is enzyme, not receptor, mediated. Science 242:583-85
39. Garren LD, Ney RL, Davis WW. 1965. Studies on the role of protein synthesis in the regulation of corticosterone production by ACTH in vivo. Proc. Natl. Acad. Sci. USA 53:1443-50
40. Geley S, Jöhrer K, Peter M, Denner K, Bernhardt R, et al. 1995. Amino acid substitution R384P in aldosterone synthase causes corticosterone methyloxidase type I deficiency. J. Clin. Endocrinol. Metab. 80:424-29
41. Gomez-Sanchez CE, Holland OB, Murray BA, Lloyd HA, Milewich L. 1979. 19-Nor-deoxycorticosterone (19-nor-DOC): mineralocorticoid isolated from the urine of rats with regenerating adrenals. Endocrinology 105:708-11
42. Gordon RD, Zlesak MD, Tunny TJ, Stowasser M, Klemm SA. 1993. Evidence that primary aldosteronism may not be uncommon: 12% incidence among antihypertensive drug trial volunteers. Clin. Exp. Pharmacol. Physiol. 20:296-98
43. Griffing GT, Melby JC, Holbrook M, Wilson T, Azar S, et al. 1991. Elevated 18-hydroxy-corticosterone in inbred salt-sensitive rats. Clin. Exp. Hypertens. 13: 371-82
44. Griffing GT, Wilson TE, Melby JC. 1985. Unconjugated and conjugated 19-nor-deoxycorticosterone glucosidu-ronate. Elevated levels in essential hypertension. Hypertension 7(Suppl. 1): I12-17
45. Griffing GT, Wilson TE, Melby JC. 1990. Alterations in aldosterone secretion and metabolism in low renin hypertension. J. Clin. Endocrinol. Metab. 71:1454-60
46. Harikrishna JA, Black SM, Szklarz GD, Miller WL. 1993. Construction and function of fusion enzymes of the human cytochrome P450scc system. DNA Cell Biol. 12:371-79
47. Hasemann CA, Kurumbail RG, Boddupalli SS, Peterson JA, Deisenhofer J. 1995. Structure and function of cytochromes P450: a comparative analysis of three crystal structures. Structure 3: 41-62
48. Hasemann CA, Ravichandran KG, Peterson JA, Deisenhofer J. 1994. Crystal structure and refinement of cytochrome P450terp at 2.3 Å resolution. J. Mol. Biol. 236:1169-85
49. Imai T, Yanase T, Waterman MR, Simpson ER, Pratt JJ. 1992. Canadian Mennonites and individuals residing in the Friesland region of the Netherlands share the same molecular basis of 17α-hydroxylase deficiency. Hum. Genet. 89:95-96
50. Komiya I, Yamada T, Aizawa T, Takasu N, Niwa A, et al. 1991. Inappropriate elevation of the aldosterone/plasma renin activity ratio in hypertensive patients with increases of 11-deoxycorticosterone and 18-hydroxy-11-deoxycorticosterone: a subtype of essential hypertension? Cardiology 78:99-110
51. Deleted in proof.
52. 4 isomerase (3β-HSD) gene: adrenal and gonadal specificity. DNA Cell Biol. 10: 701-11
53. Lin D, Black SM, Nagahama Y, Miller WL. 1993. Steroid 17α-hydroxylase and 17,20 lyase activities of P450c17: contributions of serine and P450 reductase. Endocrinology 132:2498-506
54. Lin D, Gitelman SE, Saenger P, Miller WL. 1991. Normal genes for the cholesterol side chain cleavage enzyme, P450scc, in congenital lipoid adrenal hyperplasia. J. Clin. Invest. 88:1955-62
55. Lin D, Sugawara T, Strauss JF III, Clark BJ, Stocco DM, et al. 1995. Role of steroidogenic acute regulatory protein in adrenal and gonadal sleroidogenesis. Science 267:1828-31
56. Lin D, Zhang L, Chiao E, Miller WL. 1994. Modeling and mutagenesis of the active site of human P450c17. Mol. Endocrinol. 8:392-402
57. 4 isomerase. Mol. Endocrinol. 4: 1850-55
58. Malee MP, Mellon SH. 1991. Zone-specific regulation of two distinct messenger RNAs for P450c11 (11/18-hydroxylase) in the adrenals of pregnant and non-pregnant rats. Proc. Natl. Acad. Sci. USA 88:4731-35
59. Matsukawa N, Nonaka Y, Higaki J, Nagano M, Mikami H, et al. 1993. Dahl's salt-resistant normotensive rat has mutations in cytochrome P450(11β), but the salt-sensitive hypertensive rat does not. J. Biol. Chem. 268:9117-21
60. McEwen BS, de Kloet ER, Rostene W. 1986. Adrenal steroid receptors and actions in the nervous system. Physiol. Rev. 66:1121-88
61. Mebarki F, Sanchez R, Rheaume E, Laflamme N, Simard J, et al. 1995. Non-salt-losing male pseudohermaphroditism due to the novel homozygous N100S mutation in the type II 3β-hydroxysteroid dehydrogenase gene. J. Clin. Endocrinol. Metab. 80:2127-34
62. Mellon SH, Bair SR, Monis H. 1995. P450c11B3 mRNA, transcribed from a third P450c11 gene, is expressed in a tissue-specific, developmentally and hormonally regulated fashion in the rodent adrenal, and encodes a protein with both 11-hydroxylase and 18-hydroxylase activities. J. Biol. Chem. 270:1643-49
63. Mellon SH, Miller WL. 1989. Extra-adrenal steroid 21-hydroxylation is not mediated by P450c21. J. Clin. Invest. 84:1497-502
64. Miller WL. 1988. Molecular biology of steroid hormone synthesis. Endocrin. Rev. 9:295-318
65. Miller WL. 1994. Genetics, diagnosis, and management of 21-hydroxylase deficiency. J. Clin. Endocrinol. Metab. 78:241-46
66. Miller WL. 1995. Mitochondrial specificity of the early steps in steroidogenesis. J. Steroid Biochem. Mol. Biol. 55: 607-16
67. Miller WL, Tyrrell JB. 1995. The adrenal cortex. In Endocrinology and Metabolism, P Felig, J Baxter, L Frohman, pp. 555-717. New York: McGraw Hill. 3rd ed.
68. Mitsuuchi Y, Kawamoto T, Miyahara K, Ulick S, Morton D, et al. 1993. Congenitally defective aldosterone biosynthesis in the humans: inactivation of the P-450c18 gene (CYP11B2) due to nucleotide deletion in CMO I deficient patients. Biochem. Biophys. Res. Commun. 190:864-69
69. Monder C. 1991. Corticosteroids, receptors, and the organ-specific functions of 11β-hydroxysteroid dehydrogenase. FASEB J. 5:3047-54
70. Moore CCD, Brentano ST, Miller WL. 1990. Human P450scc gene transcription is induced by cyclic AMP and repressed by 12-O-tetradecanolyphorbol-13-acetate and A23187 by independent cis-elements. Mol. Cell Biol. 10:6013-23
71. Moore CCD, Mellon SH, Murai J, Siiteri PK, Miller WL. 1993. Structure and function of the model hepatic form of 11β-hydroxysteroid dehydrogenase in the squirrel monkey, an animal model of glucocorticoid resistance. Endocrinology 133:368-75
72. Morel Y, Miller WL. 1991. Clinical and molecular genetics of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Adv. Hum. Genet. 20:1-68
73. Mukai K, Imai M, Shimada H, Ishimura Y. 1993. Isolation and characterization of rat CYP11B genes involved in late steps of mineralo- and glucocorticoid syntheses. J. Biol. Chem. 268:9130-37
74. Mune T, Rogerson FM, Nikkila H, Agarwal AK, White PC. 1995. Human hypertension caused by mutations in the kidney isozyme of 11 beta-hydroxysteroid dehydrogenase. Nature Genet. 10: 394-99
75. Nelson DR, Strobel HW. 1988. On the membrane topology of vertebrate cytochrome P-450 proteins. J. Biol. Chem. 263:6038-50
76. Nonaka Y, Okamoto M. 1991. Functional expression of the cDNAs encoding rat 11β-hydroxylase (cytochrome P45011β) and aldosterone synthase (cytochrome P45011β, aldo). Eur. J. Biochem. 202:897-902
77. Ogishima T, Suzuki H, Itala J, Mitani F, Ishimura Y. 1992. Zone-specific expression of aldosterone synthase cytochrome P450 and cytochrome P450-11β in rat adrenal cortex: histochemical basis for the functional zonation. Endocrinology 130:2971-77
78. Oguchi A, Ikeda U, Kanbe T, Tsuruya Y, Yamamoto K, et al. 1993. Regulation of Na-K-ATPase gene expression by aldosterone in vascular smooth muscle cells. Am. J Phvsiol. 265:H1167-72
79. Ohta MJ, Fujii S, Wada A, Ohnishi T, Yamano T, Okamoto M. 1987. Production of 19-hydroxy-11-deoxycorticosterone by cytochrome P-45011. J. Steroid Biochem. 26:73-81
80. Papadopoulos V. 1993. Peripheral-type benzodiazepine/diazepam binding inhibitor receptor: biological role in steroidogenic cell function. Endocrin. Rev. 14:222-40
81. Pascoe L, Curnow K, Slutsker L, Rösler A, White PC. 1992. Mutations in the human CYP11B2 (aldosterone synthase) gene causing corticosterone methyloxidase II deficiency. Proc. Natl. Acad. Sci. USA 89:4996-5000
82. Picado-Leonard J, Miller WL. 1988. Homologous sequences in steroidogenic enzymes, steroid receptors and a steroid binding protein suggest a consensus steroid-binding sequence. Mol. Endocrinol. 2:1145-50
83. Picard D, Khursheed B, Garabedian MJ, Fortin M, Lindquist S, Yamamoto KR. 1990. Reduced levels of hsp90 compromise steroid receptor action in vivo. Nature 348:166-68
84. Quinn SJ, Williams GH. 1988. Regulation of aldosterone secretion. Annu. Rev. Physiol. 50:409-26
85. Rafestin-Oblin ME, Coletter B, Radanyi C, Lombès M, Baulieu EE. 1989. Mineralocorticoid receptor of the chick intestine: oligomeric structure and transformation. J. Biol. Chem. 264: 9304-9
86. Rapp JP. 1982. Dahl salt-susceptible and salt-resistant rats. A review. Hypertension 4:753-63
87. Rapp JP. 1983. Genetics of experimental hypertension. In Hypertension, Pathophysiology and Treatment, ed. J Genest, O Kuchel, P Hamet, M Cantin, pp. 582-98. New York: McGraw-Hill. 2nd ed.
88. Rapp JP, Dene H. 1985. Development and characteristics of inbred strains of Dahl salt-sensitive and salt-resistant rats. Hypertension 7:340-49
89. Ravichandran KG, Boddupalli SS, Hasemann CA, Peterson JA, Deisenhofer J. 1993. Crystal structure of hemoprotein domain of P450BM-3, a prototype for microsomal P450's. Science 261:731-36
90. Renoir J, Radanyi C, Faber LE, Baulieu EE. 1990. The non-DNA-binding heterooligomeric form of mammalian steroid hormone receptors contain a hsp 90-bound 59 kilodalton protein. J. Biol. Chem. 265:10740-45
91. 4-isomerase in human adrenals and gonads. Mol. Endocrinol. 5:1147-57
92. Rhéaume E, Sanchez R, Mébarki F, Gagnon E, Carel J-C, et al. 1995. Identification and characterization of the G15D mutation found in a male patient with 3β-hydroxysteroid dehydrogenase (3β-HSD) deficiency: alteration of the putative NAD-binding domain of type II 3β-HSD. Biochemistry 34:2893-900
93. Rhéaume E, Sanchez R, Simard J, Change YT, Wang J, et al. 1994. Molecular basis of congenital adrenal hyperplasia in two siblings with classical nonsalt-losing 3β-hydroxysteroid dehydrogenase deficiency. J. Clin. Endocrinol. Metab. 79:1012-18
94. Rohmer V, Barbot N, Bertrand P, Hanoul K, Bigorgne JC, Forest MG. 1990. A case of male pseudohermaph-roditism due to 17α-hydroxylse deficiency and hormonal profiles in the nuclear family. J. Clin. Endocrinol. Metab. 71:523-29
95. Rosenthal T, Shani M, Peleg E, Harnik M. 1988. The hypertensinogenic activity of 18-hydroxy-19-norcorticosterone in the adrenalectomized rat. Am. J. Hypertens. 1:49S-52S
96. Rösler A. 1984. The natural history of salt-wasting disorders of adrenal and renal origin. J. Clin. Endocrinol. Metab. 59:689-700
97. Rösler A, Leiberman E, Cohen T. 1992. High frequency of congenital adrenal hyperplasia (classic 11-beta-hydroxylase deficiency) among Jews from Morocco. Am. J. Med. Genet. 42:827-34
98. Rupprecht R, Reul JMHM, van Steensel B, Spengler D, Söder M, et al. 1993. Pharmacological and functional characterization of human mineralocorticoid and glucccorticoid receptor ligands. Eur. J. Pharm. 247:145-54
99. Russel RP, Masi AT. 1973. Significant associations of adrenal cortical abnormalities with 'essential' hypertension. Am. J. Med. 54:44-51
100. Rusvai E, Náray-Fejes-Tóth A. 1993. A new isoform of 11β-hydroxysteroid dehydrogenase in aldosterone target cells. J. Biol. Chem. 268:10717-20
101. Sanchez E, Faber L, Henzel M, Proatt W. 1990. The 56-59 kilodalton protein identified in untransformed steroid receptor complexes is a unique protein that exists in cytosol in a complex with both the 70- and 90-kilodalton beat shock protein. Biochemistry 29:5145-52
102. Sanchez R, Mebarki F, Rheaume E, Laflamme N, Forest MG, et al. 1994. Functional characterization of the novel L108W and P186L mutations detected in the type II 3 β-hydroxysteroid dehydrogenase gene of a male pseudohermaphrodite with congenital adrenal hyperplasia. Hum. Mol. Genet. 3:1639-45
103. Sanchez R, Rheaume E, Laflamme N, Rosenfield RL, Labrie F, Simard J. 1994. Detection and functional characterization of the novel missense mutation Y254D in type II 3β-hydroxysteroid dehydrogenase (3βHSD) gene of a female patient with nonsalt-losing 3βHSD deficiency. J. Clin. Endocrinol. Metab. 78:561-67
104. Sander M, Ganten D, Mellon SH. 1994. Role of adrenal renin in the regulation of adrenal steroidogenesis by ACTH. Proc. Natl. Acad. Sci. USA 91:148-52
105. Schulman G, Miller-Diener A, Litwach G, Bastl CP. 1986. Characterization of the rat colonic aldosterone receptor and its activation process. J. Biol. Chem. 261:12102-8
106. Simard J, Rhéaume E, Leblanc J-F, Wallis SC, Joplin GF, et al. 1994. Congenital adrenal hyperplasia caused by a novel homozygous frameshift mutation 273DAA in type II 3β-hydroxysteroid dehydrogenase gene (HSD3B2) in three male patients of Afghan/Pakistani origin. Hum. Mol. Genet. 3:327-30
107. Simard J, Rheaume E, Sanchez R, Laflamme N, de Launoit Y, et al. 1993. Molecular basis of congenital adrenal hyperplasia due to 3β-hydroxysteroid dehydrogenase deficiency. Mol. Endocrinol. 7:716-28
108. Smith J, Faber L, Toft D. 1990. Purification of unactivated progesterone receptor and identification of novel receptor-associated proteins. J. Biol. Chem. 265:3996-4003
109. Speiser PW, Agdere L, Veshiba H, White PC, New MI. 1991. Aldosterone synthesis in patients with salt-wasting congenital adrenal hyperplasia (21-hydroxylase deficiency) and complete absence of adrenal 21-hydroxylase (P450c21). N. Engl. J. Med. 3221:145-49
110. Stewart PM, Corrie JET, Shackleton CHL, Edward CRW. 1988. Syndrome of apparent mineralocorticoid excess. A defect in the cortisol-cortisone shuttle. J. Clin. Invest. 82:340-49
111. Stewart PM, Wallace AM, Atherden SM, Shearing CH, Edwards CRW. 1990. Mineralocorticoid activity of carbenoxolone: contrasting effects of carbenoxolone and liquorice on 11β-hydroxysteroid dehydrogenase activity in man. Clin. Sci. 78:49-54
112. Stocco DM, Sodeman TC. 1991. The 30 kDa mitochondrial protein induced by hormone stimulation in MA-10 mouse Leydig tumor cells are processed from larger precursors. J. Biol. Chem. 266:19731-38
113. Sugawara T, Holt JA, Driscoll D, Strauss JF III, Lin D, et al. 1995. Human steroidogenic acute regulatory protein (StAR): functional activity in COS-1 cells, tissue-specific expression, and mapping of the structural gene to 8p11.2 and an expressed pseudogene to chromosome 13. Proc. Natl. Acad. Sci. USA 92:4778-82
114. Sugawara T, Lin D, Holt JA, Martin KO, Javitt NB, et al. 1995. The structure of the human steroidogenic acute regulatory (StAR) protein gene: StAR stimulates mitochondrial cholesterol 27-hydroxylase activity. Biochemistry 34: 12506-12
115. Takeda Y, Miyamori I, Takeda R. 1995. Significance of 19-nor aldosterone, a new mineralocorticoid, in clinical and experimental hypertension. Steroids 60: 137-42
116. Tannin GM, Agarwal AK, Monder C, New MI, White PC. 1991. The human gene for 11β-hydroxysteroid dehydrogenase. Structure, tissue distribution, and chromosomal localization. J. Biol. Chem. 266:16653-58
117. Tee MK, Lin D, Sugawara T, Holt JA, Guiguen Y, et al. 1995. T→A transversion 11 bp from a splice acceptor site in the gene for steroidogenic acute regulatory protein causes congenital lipoid adrenal hyperplasia. Hum. Mol. Genet. 4:2299-305
118. Todd-Turla KM, Schnermann J, Fejes-Tóth G, Naray-Fejes-Tóth A, Smart A, et al. 1993. Distribution of mineralocorticoid receptor mRNA along the nephron. Am. Phys. Soc. 264:F781-91
119. Tremblay A, Parker KL, Lehoux JG. 1992. Dietary potassium supplementation and sodium restriction stimulate aldosterone synthase but not 11β-hydroxylase P450 messenger ribonucleic acid accumulation in rat adrenals and require angiotensin II production. Endocrinology 130:3152-58
120. Ulick S, Wang JZ, Morton H. 1992. The biochemical phenotypes of two inborn errors in the biosynthesis of aldosterone. J. Clin. Endocrinol. Metab. 74: 1415-20
121. Wagner MJ, Ge Y, Siciliano M, Wells DE. 1991. A hybrid cell mapping panel for regional localization of probes to human chromosome 8. Genomics 10: 114-25
122. White PC, Curnow KM, Pascoe L. 1994. Disorders of steroid 11β-hydroxylase isozymes. Endocrin. Rev. 15: 421-38
123. White PC, Dupont J, New MI, Lieberman E, Hochberg Z, Rösler A. 1991. A mutation in CYP11B1 (Arg 448→His) associated with steroid 11β-hydroxylase deficiency in Jews of Moroccan origin. J. Clin. Invest. 87:1664-67
124. Williams G, Moore T, Hollenberg N. 1991. Dysregulation of aldosterone secretion and its relationship to the pathogenesis of essential hypertension. Endocrinol. Metab. Clin. North. Am. 20: 423
125. Wilson RC, Krozowski ZS, Li K, Obeyesekere VR, Razzaghy-Azar M, et al. 1995. A mutation in the HSD11B2 gene in a family with apparent mineralocorticoid excess. J. Clin. Endocrinol. Metab. 80:2263-66
126. Wit JM, Van Roermund HPC, Oostdijk W. 1988. Heterozygotes for 17α-hydroxylase deficiency can be detected with a short ACTH test. Clin. Endocrinol. 28:657-64
127. Yanase T, Simpson ER, Waterman MR. 1991. 17α-Hydroxylase/17,20 lyase deficiency: from clinical investigation to molecular definition. Endocrin. Rev. 12: 91-108
128. Yanase T, Waterman MR, Zachmann M, Winter JSD, Simpson ER, Kagimoto M. 1992. Molecular basis of apparent isolated 17,20-lyase deficiency: compound heterozygous mutations in the C-terminal region (Arg(496)→Cys, Gln(461)→Stop) actually cause combined 17α-hydroxylase/17,20-lyase deficiency. Biochim. Biophys. Acta 1139: 275-79
129. Zerah M, Rhéaume E, Mani P, Schram P, Simard J, et al. 1994. No evidence of mutations in the genes for type I and type II 3β-hydroxysteroid dehydrogenase (3βHSD) in nonclassical 3βHSD deficiency. J. Clin. Endocrinol. Metab. 79:1811-17
130. Zhang G, Rodriguez H, Fardella CE, Harris DA, Miller WL. 1995. Mutation T318M in P450c11AS causes corticos-terone methyl oxidase II deficiency. Am. J. Hum. Genet. 57:1037-43